全球血清学检测市场 – 行业趋势及 2030 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

全球血清学检测市场 – 行业趋势及 2030 年预测

  • Healthcare IT
  • Upcoming Report
  • Dec 2022
  • Global
  • 350 页面
  • 桌子數: 220
  • 图号: 60

Global Serological Testing Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2023 –2030
Diagram Market Size (Base Year)
USD 4.52 Billion
Diagram Market Size (Forecast Year)
USD 7.60 Billion
Diagram CAGR
%
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

>全球血清学检测市场,按检测类型(初级血清学检测、二级血清学检测、三级结合检测)、应用(轮状病毒感染、肝炎、艾滋病毒、内毒素、治疗药物监测、其他传染病)、最终用户(医院、诊断实验室、血库、学术和研究机构、其他)、最终用户(医院和诊所、诊断实验室、其他)– 行业趋势和预测到 2030 年。

全球血清学检测市场

血清学检测市场分析和规模

根据美国疾病控制与预防中心的数据,2019 年美国登记了约 34,800 例新的HIV病例。不同的血清学测试用于识别抗体或抗原。市场参与者开发的解决方案和产品的一些最重要应用包括轮状病毒感染、治疗药物监测、艾滋病毒、肝炎、内毒素和其他传染病

Data Bridge Market Research 分析,血清学检测市场预计到 2030 年将达到 76 亿美元,即 2022 年为 45.2 亿美元,预计在 2023 年至 2030 年的预测期内复合年增长率为 6.70%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外,Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。

血清学检测市场范围和细分

报告指标

细节

预测期

2023 至 2030 年

基准年

2022

历史岁月

2021(可定制为 2015 - 2020)

定量单位

收入(单位:十亿美元)、销量(单位:台)、定价(美元)

涵盖的领域

检测类型(初级血清学检测、次级血清学检测、三级结合检测)、应用(轮状病毒感染、肝炎、艾滋病毒、内毒素、治疗药物监测、其他传染病)、最终用户(医院、诊断实验室、血库、学术和研究机构、其他)、最终用户(医院、创伤中心、门诊手术中心等)

覆盖国家

北美洲的美国、加拿大和墨西哥、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、巴西、阿根廷和南美洲其他地区

涵盖的市场参与者

Serological Research Institute (SERI) (U.K.), Chembio Diagnostics, Inc (U.S.), Cellex (U.S.), Randox Laboratories Ltd (U.K.), Abbott (U.S.), Bio-Rad Laboratories Inc. (U.S.), BD (U.S.), Thermo Fisher Scientific Inc. (U.S.), and Ortho Clinical Diagnostics (U.S.), Quest Diagnostics Incorporated (U.S), Abcam Plc (U.K.), F. Hoffmann-La Roche Ltd. (Switzerland), ELITechGroup (France), Teleflex Incorporated (U.S.), Grifols, S.A. (U.S.), Global Scientific Company(India), Beckman Coulter, Inc. (U.S.), BIOMEDOMICS INC. (U.S.), Creative Diagnostics (U.S.)

Market Opportunities

  • Growing Demand of ELISA
  • Increasing Incidence of Tuberculosis

Market Definition

Serology tests are used to identify antibodies or antigens. When the body comes in contact with an antigen, the immune system releases antibodies as a defense mechanism and tries to normalize the antigen. In serological testing, such antigens and antibodies are validated for the diagnosis of a specific disease and condition that further helps doctors give proper medical treatment. Serology testing is done by numerous methods such as enzyme-linked immunosorbent assays (ELISAs), hemagglutinin-inhibition tests, flocculation tests, chemiluminescence immunoassays and neutralization tests

Serological Testing Market Dynamics

Drivers

  • Increasing usage of chemiluminescence immunoassay

The market is witnessing a major shift away from the traditional ELISA method and moving towards the use of CLIA. Disease complications have surged the need to detect smaller target molecules, which leads to the emergence of CLIA. It is used in combination with a directly labelling antigen (antibody) and an indicator such as isoluminol, luminol, or an acridinium ester. The increasing sensitivity and accuracy of chemiluminescence immunoassay over enzyme-linked immunosorbent assay (ELISA) is anticipated to drive the market growth.

  • Increase in Antibody Test

The antibody test contributes to the market growth. This dominance is due to the benefits of antibody tests and several advancements in the testing of the serological virus. The high demand for other tests such as viral load tests, genotype tests are going to increase in the forecast period because of the improvements and test accuracies and adoption by expert professionals.

Opportunities

  • Growing Demand of ELISA

ELISA is of great demand and leading the market due to less turnaround time for testing, long self-life of regents, cheap and affordable reagents, a high number of infectious diseases screenings, high specificity, high sensitivity, and ELISA analyzers are inexpensive. Moreover, technological advancement, less complex steps required for performing, high precision screening, and many several key players are contributing to the growth of ELISA testing segment.

  • Increasing Incidence of Tuberculosis

There has been increasing incidence of TB in the recent years that lead to the growth of the serological testing. India's TB incidence for the year 2021 is 210 per 100,000 population than the baseline year of 2015. The incidence was 256 per lakh of population in India and there has been an 18% deterioration. TB is the 13th leading cause of death worldwide and the second leading cause of infectious killer after COVID-19.

Restraints/Challenges

  • High cost of Diagnostic Tests

There has been numerous tests that are hugely available for testing hepatitis diseases. But these tests are of increasing cost that is not afforded by numerous patients, mainly belonging to the lower economic groups. Thus, it hampers the market growth.

This serological testing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the serological testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

  • In 2021, Seimens and Hemogenomics made a clinical trial to do an extensive evaluation of the ADVIA Centaur XP chemiluminescence system.
  • In 2019, Mylab Disocovery Solutions launched NATSpert, which is used to screen HIV, HBV, HCV in donated blood.

Global Serological Testing Market Scope

The serological testing market is segmented on the basis of test type, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Test Type

  • Primary Serological Tests
  • Enzyme Linked Immunosorbent Assay (ELISA)
  • Immunoflurescent Antibody Technique (IFAT)
  • Radio Immunoassay (RIA)
  • Secondary Serological Tests
  • Agglutination Tests
  • Complement Fixation Tests (CFT)
  • Precipitation Tests
  • Serum Neutralization Tests (SNT)
  • Toxin-antitoxin Tests
  • Tertiary Binding Tests

Application

  • Rotavirus Infections
  • Hepatitis
  • HIV
  • Endotoxins
  • Therapeutic Drug Monitoring
  • Other Infectious Diseases

End-user

  • Hospital and Clinics
  • Diagnostic Laboratories
  • Blood Banks
  • Diagnostic Laboratories
  • Others

Serological Testing Regional Analysis/Insights

The serological testing market is analyzed and market size insights and trends are provided by test type, application and end-user as referenced above.

血清学检测市场报告涵盖的国家包括北美的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区(APAC)的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲(MEA)的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。

由于北美传染病发病率不断上升、医疗基础设施完善以及老年人口不断增加,北美在血清学检测市场占据主导地位。

由于人们认识的提高、人均医疗保健支出的增加以及印度和中国等发展中国家传染病发病率的上升,预计亚太地区将在 2023 年至 2030 年的预测期内以最高的增长率增长。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化,这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外,在提供国家数据的预测分析时,还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。   

医疗保健基础设施增长安装基础和新技术渗透

血清学检测市场还为您提供每个国家/地区资本设备医疗保健支出增长、血清学检测市场不同类型产品的安装基数、使用生命线曲线的技术的影响以及医疗保健监管情景的变化及其对血清学检测市场的影响的详细市场分析。数据适用于 2011-2021 年的历史时期。

竞争格局和全球血清学检测市场份额分析

血清学检测市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对血清学检测市场的关注有关。

血清学检测市场的一些主要参与者包括:

  • 血清学研究所(SERI)(英国)
  • Chembio Diagnostics, Inc(美国)
  • Cellex (美国)
  • Randox Laboratories Ltd(英国)
  •  雅培(美国)
  • Bio-Rad Laboratories Inc.(美国)
  • BD(美国)
  • 赛默飞世尔科技公司(美国)
  • Ortho Clinical Diagnostics(美国)
  • Quest Diagnostics Incorporated(美国)
  • Abcam Plc(英国)
  • F. Hoffmann-La Roche Ltd.(瑞士)
  • ELITechGroup(法国)
  • Teleflex Incorporated(美国)
  • Grifols, SA(美国)
  • 全球科学公司(印度)
  • 贝克曼库尔特公司(美国)
  • BIOMEDOMICS INC.(美国)
  • Creative Diagnostics(美国)


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The serological testing market size will be worth USD 7.6 billion by 2030.
The growth rate of the serological testing market is 6.70%.
Increasing usage of chemiluminescence immunoassay & increase in antibody test are the growth drivers of the serological testing market.
Test type, application and end-user are the factors on which the serological testing market research is based.
Major companies in the serological testing market are Serological Research Institute (SERI) (U.K.), Chembio Diagnostics, Inc (U.S.), Cellex (U.S.), Randox Laboratories Ltd (U.K.), Abbott (U.S.), Bio-Rad Laboratories Inc. (U.S.), BD (U.S.), Thermo Fisher Scientific Inc. (U.S.), and Ortho Clinical Diagnostics (U.S.), Quest Diagnostics Incorporated (U.S), Abcam Plc (U.K.), F. Hoffmann-La Roche Ltd. (Switzerland), ELITechGroup (France), Teleflex Incorporated (U.S.), Grifols, S.A. (U.S.), Global Scientific Company(India), Beckman Coulter, Inc. (U.S.), BIOMEDOMICS INC. (U.S.), Creative Diagnostics (U.S.).